scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Shu Man Fu | Q57174082 |
P2093 | author name string | Felicia Gaskin | |
Umesh S Deshmukh | |||
P2860 | cites work | Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci | Q24306903 |
Epitope mapping of recombinant HeLa SmB and B' peptides obtained by the polymerase chain reaction | Q28261450 | ||
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX | Q28265206 | ||
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens | Q30305719 | ||
NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci | Q30307755 | ||
Immune responses to small nuclear ribonucleoproteins: antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins | Q30309300 | ||
Mechanisms of Autoantibody Diversification to SLE‐Related Autoantigens | Q30310820 | ||
Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis | Q30312212 | ||
Differential responses to Smith D autoantigen by mice with HLA-DR and HLA-DQ transgenes: dominant responses by HLA-DR3 transgenic mice with diversification of autoantibodies to small nuclear ribonucleoprotein, double-stranded DNA, and nuclear antige | Q30433491 | ||
Epitope spreading within lupus-associated ribonucleoprotein antigens | Q30437751 | ||
Evidence for multiple shared antigenic determinants within Ro60 and other lupus-related ribonucleoprotein autoantigens in human autoimmune responses | Q30438749 | ||
Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies | Q30442810 | ||
A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading | Q30442830 | ||
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry | Q33364289 | ||
A novel mechanism of thrombosis in antiphospholipid antibody syndrome. | Q33390825 | ||
Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity | Q33488126 | ||
60 kD Ro and nRNP A frequently initiate human lupus autoimmunity. | Q33540161 | ||
New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects | Q33741182 | ||
The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes | Q34104677 | ||
The blood nucleome in the pathogenesis of SLE | Q34415680 | ||
Lessons from an anti-DNA autoantibody | Q35013745 | ||
Genetic and hormonal factors in female-biased autoimmunity | Q35208512 | ||
Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. | Q35795846 | ||
Polyspecificity of T cell and B cell receptor recognition | Q36082439 | ||
Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus | Q36342233 | ||
Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. | Q37218887 | ||
Review of recent genome-wide association scans in lupus | Q37506571 | ||
Clustering and commonalities among autoimmune diseases | Q37616846 | ||
Drugs and autoimmunity--a contemporary review and mechanistic approach | Q37656623 | ||
The implications of autoimmunity and pregnancy | Q37661793 | ||
Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. | Q37661794 | ||
Defining and analyzing geoepidemiology and human autoimmunity | Q37662596 | ||
Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium | Q37746114 | ||
B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. | Q37748142 | ||
Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells | Q37773617 | ||
Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids | Q37773618 | ||
Autoimmunity and chronic inflammation - two clearance-related steps in the etiopathogenesis of SLE. | Q37785320 | ||
Updating on the pathogenesis of systemic lupus erythematosus | Q37791687 | ||
Salivary epithelial cells from Sjogren’s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation | Q39671473 | ||
Immunologic observations on 9 sets of twins either concordant or discordant for SLE | Q39774756 | ||
Studies in familial systemic lupus erythematosus | Q40565059 | ||
B-Lymphocyte Alloantigens Associated with Systemic Lupus Erythematosus | Q40686448 | ||
The lupus autoantigens and the pathogenesis of systemic lupus erythematosus | Q41355812 | ||
Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide | Q41466505 | ||
Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals. | Q41511542 | ||
Serologic studies of monozygotic twins with systemic lupus erythematosus | Q42610316 | ||
HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules | Q44002250 | ||
Geo-epidemiology and autoimmunity. | Q45945320 | ||
A revised estimate of twin concordance in systemic lupus erythematosus | Q46504033 | ||
Haralampos M. Moutsopoulos: A lifetime in autoimmunity | Q48459103 | ||
Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose | Q48482452 | ||
The international symposium on Sjögren's syndrome in Brest: the "top of the tops" at the "tip of the tips". | Q53173922 | ||
Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. | Q53855301 | ||
Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus | Q68951831 | ||
Murine models of systemic lupus erythematosus | Q69894910 | ||
Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization | Q70673185 | ||
[Systemic lupus erythematosus preceded by false-positive serologic tests for syphilis: presentation of five cases] | Q73949259 | ||
Susceptibility to lupus nephritis in the NZB/W model system | Q77892082 | ||
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus | Q79171865 | ||
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals | Q84510281 | ||
Systemic lupus erythematosus and the SLE galaxy | Q85072604 | ||
P433 | issue | 2 | |
P921 | main subject | autoantibody | Q785022 |
systemic lupus erythematosus | Q1485 | ||
pathogenesis | Q372016 | ||
P304 | page(s) | 104-112 | |
P577 | publication date | 2011-06-01 | |
P1433 | published in | Journal of Autoimmunity | Q15716783 |
P1476 | title | Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR. | |
P478 | volume | 37 |
Q55479438 | Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis. |
Q38021696 | Autoimmunity in 2011. |
Q30418064 | Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. |
Q34172246 | Autoreactivity to glucose regulated protein 78 links emphysema and osteoporosis in smokers |
Q36023695 | Beneficial effect of Bupleurum polysaccharides on autoimmune-prone MRL-lpr mice |
Q48338382 | Characterization of a PRISTANE-induced lupus-associated model in the non-human primate cynomolgus monkey. |
Q33778956 | Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse |
Q37127290 | Costimulatory pathways: physiology and potential therapeutic manipulation in systemic lupus erythematosus |
Q51147794 | Detection of epitopes in systemic lupus erythematosus using peptide microarray. |
Q37498733 | Differential effects of palmitoleic acid on human lymphocyte proliferation and function. |
Q34103945 | Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells |
Q38396871 | Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis |
Q30301191 | Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage |
Q30424263 | HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD |
Q52603672 | Human leukocyte antigens-DRB1*03 is associated with systemic lupus erythematosus and anti-SSB production in South Tunisia. |
Q97067624 | IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production |
Q34087313 | Immunologic characteristics of intrarenal T cells: trafficking of expanded CD8+ T cell β-chain clonotypes in progressive lupus nephritis |
Q33669140 | Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads |
Q36016443 | Megakaryocyte progenitors are the main APCs inducing Th17 response to lupus autoantigens and foreign antigens |
Q37306030 | Methyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction |
Q63976951 | Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification |
Q36917458 | Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses |
Q37243946 | Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients |
Q36739751 | Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. |
Q47131684 | Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation |
Q45376906 | Screening epitopes on systemic lupus erythematosus autoantigens with a peptide array |
Q39739836 | Self-Organized Criticality Theory and the Expansion of PD-1-Positive Effector CD4 T Cells: Search for Autoantibody-Inducing CD4 T Cells |
Q35672923 | Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets. |
Q38067132 | Serum autoantibodies for the diagnosis and management of autoimmune liver diseases |
Q30405454 | T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria |
Q38051261 | The autoimmune side of heart and lung diseases |
Q38077485 | The implication of vitamin D and autoimmunity: a comprehensive review |
Q38028889 | The long-term marriage between autoimmunity and internal medicine: a homage to Manuel Carlos Dias |
Q37967566 | The therapeutic potential of epigenetics in autoimmune diseases. |
Q38864797 | Update on Biologic Therapies for Systemic Lupus Erythematosus |
Q35113415 | Violation of an evolutionarily conserved immunoglobulin diversity gene sequence preference promotes production of dsDNA-specific IgG antibodies. |
Search more.